S-3029-115
Became Public Law No: 115-328.
What it does
This bill extends federal funding and programs related to premature birth research and education through fiscal year 2023. It requires the Centers for Disease Control and Prevention (CDC) to publish its preterm birth research report on its public website. It also expands the topics covered by preterm birth educational programs to include information on substance-use disorders, depression, and immunization.
Who benefits
Pregnant women and those at risk of preterm birth, particularly those dealing with substance-use disorders or depression, who would gain access to more comprehensive educational resources. Healthcare providers who counsel pregnant patients would have federally supported materials covering a broader range of health topics. Researchers studying premature birth would benefit from continued federal funding. The general public gains easier access to CDC preterm birth research through mandatory web publication.
Who is hurt
Taxpayers who oppose continued or expanded federal spending on public health education programs bear the cost of reauthorization through FY2023. Organizations or providers that currently deliver preterm birth education may face administrative adjustments to incorporate the newly required topics into their existing curricula and materials.
Supporters argue
Supporters argue that preterm birth is the leading cause of infant death in the United States, affecting roughly 1 in 10 births annually, making continued federal research and education essential. They contend that expanding educational content to include substance-use disorders, depression, and immunization reflects the medical reality that these conditions directly affect pregnancy outcomes. Requiring the CDC to post its research online increases government transparency and ensures that healthcare providers and families can access the latest findings at no cost. Reauthorizing the program through 2023 provides stable, predictable funding that allows researchers and educators to plan long-term initiatives rather than operating year to year.
Opponents argue
Opponents argue that reauthorizing and expanding the program adds to federal spending without a rigorous evaluation of whether prior funding produced measurable improvements in preterm birth rates or infant health outcomes. They contend that substance-use disorders, depression, and immunization are already addressed by separate, dedicated federal programs, making their inclusion here duplicative and an inefficient use of resources. Critics may also argue that mandating specific educational content at the federal level displaces the judgment of state health agencies and local providers who are better positioned to tailor programs to their communities' needs. From a fiscal standpoint, extending the authorization through 2023 commits future Congresses to spending priorities set today without guaranteed accountability measures.